Patrick Hargutt
Fondatore presso Stanley Capital Partners LLP
Posizioni attive di Patrick Hargutt
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Stanley Capital Partners LLP
 Stanley Capital Partners LLP Investment ManagersFinance Stanley Capital Partners LLP (Stanley Capital) is a private equity firm founded in 2019 by James Brooks, Patrick Hargutt and Simon W. Cottle. The firm is headquartered in London, United Kingdom. | Fondatore | 01/01/2020 | - |
| Investitore di Private Equity | 01/01/2020 | - | |
Noden Pharma DAC
 Noden Pharma DAC Pharmaceuticals: MajorHealth Technology Noden Pharma DAC is a pharmaceutical company, which engages in the acquisition of prescription medicines across a range of therapeutic areas. It manufactures, markets, and sells Tekturna and Tekturna HCT, which contain aliskiren, a direct renin inhibitor, for the treatment of hypertension. The company is headquartered in Dublin, Ireland. | Direttore/Membro del Consiglio | 01/09/2020 | - |
Laboratoire X.O
 Laboratoire X.O Pharmaceuticals: MajorHealth Technology Laboratoire X.O SAS engages in the manufacture and development of pharmaceutical products and medications. The company was founded in 2015 and is headquartered in Paris, France. | Direttore/Membro del Consiglio | 01/09/2022 | - |
| Stanley Lab, Inc. | Direttore/Membro del Consiglio | 01/03/2021 | - |
Storia della carriera di Patrick Hargutt
Precedenti posizioni note di Patrick Hargutt
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| HEALTHCARE AI ACQUISITION CORP. | Direttore/Membro del Consiglio | - | 12/06/2023 |
| Direttore Finanziario/CFO | - | 12/06/2023 | |
Monarch Alternative Capital (Private Equity)
 Monarch Alternative Capital (Private Equity) Investment ManagersFinance Monarch Alternative Capital(private equity) is a private equity firm founded in 2002. The firm is headquartered in New York with additional office in London. | Investitore di Private Equity | 01/01/2018 | 31/10/2019 |
Formazione di Patrick Hargutt
| Technische Universität München | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Germania | 2 |
| Francia | 2 |
Posizioni
| Director/Board Member | 4 |
| Private Equity Investor | 2 |
| Founder | 1 |
Settori
| Finance | 4 |
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| HEALTHCARE AI ACQUISITION CORP. | Finance |
| Aziende private | 5 |
|---|---|
| Stanley Lab, Inc. | |
Laboratoire X.O
Laboratoire X.O Pharmaceuticals: MajorHealth Technology Laboratoire X.O SAS engages in the manufacture and development of pharmaceutical products and medications. The company was founded in 2015 and is headquartered in Paris, France. | Health Technology |
Monarch Alternative Capital (Private Equity)
Monarch Alternative Capital (Private Equity) Investment ManagersFinance Monarch Alternative Capital(private equity) is a private equity firm founded in 2002. The firm is headquartered in New York with additional office in London. | Finance |
Noden Pharma DAC
Noden Pharma DAC Pharmaceuticals: MajorHealth Technology Noden Pharma DAC is a pharmaceutical company, which engages in the acquisition of prescription medicines across a range of therapeutic areas. It manufactures, markets, and sells Tekturna and Tekturna HCT, which contain aliskiren, a direct renin inhibitor, for the treatment of hypertension. The company is headquartered in Dublin, Ireland. | Health Technology |
Stanley Capital Partners LLP
Stanley Capital Partners LLP Investment ManagersFinance Stanley Capital Partners LLP (Stanley Capital) is a private equity firm founded in 2019 by James Brooks, Patrick Hargutt and Simon W. Cottle. The firm is headquartered in London, United Kingdom. | Finance |
- Borsa valori
- Insiders
- Patrick Hargutt
- Esperienza
